EUCLIDEAN CAPITAL LLC
Q2 2025 Form 13-F
NEW YORK, NEW YORK
CIK 0001825034
· Institutional investment manager
$305.7M Reported Value Total
Reported value
$305.7M
Quarter over quarter
+11.2%
Holdings
11
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Joseph Cosmai
Manager
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2025 13F record
Q2 2025 13F filing summary
| Period of report | June 30, 2025 |
|---|---|
| Filed | August 14, 2025 |
| Form | 13F-HR |
| Reported value | $305.7M |
| Positions | 11 |
| Change in reported value | +14.9% |
| New positions | 1 |
| Exited positions | 1 |
| Position turnover | 16.7% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
10 | $323.6M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
11 | $439.8M |
|
Q1 2026 13F
Filed May 15, 2026
|
10 | $392.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
12 | $369.5M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
11 | $238.0M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
11 | $305.7M |
|
Q1 2025 13F
Filed May 15, 2025
|
11 | $266.1M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
11 | $736.7M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
12 | $906.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
11 | $795.8M |
|
Q1 2024 13F
Filed May 15, 2024
|
13 | $780.0M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
13 | $888.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
13 | $458.4M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
12 | $389.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
10 | $114.0M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
11 | $106.9M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
10 | $107.7M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
10 | $117.6M |
|
Q1 2022 13F
Filed May 16, 2022
|
11 | $172.1M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
11 | $175.9M |
4 earlier quarters on file — choose one from the quarter menu above.
Top 11 holdings · Q2 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | VEU VANGUARD INTL EQUITY INDEX F | $144.0M | 47.11% |
| 2 | INDA ISHARES TR | $135.0M | 44.17% |
| 3 | ORIC ORIC PHARMACEUTICALS INC | $10.0M | 3.28% |
| 4 | FHTX FOGHORN THERAPEUTICS INC | $7.4M | 2.42% |
| 5 | PMVP PMV PHARMACEUTICALS INC | $2.8M | 0.91% |
| 6 | SPY SPDR S&P 500 ETF TR | $2.5M | 0.83% |
| 7 | ALEC ALECTOR INC | $1.8M | 0.6% |
| 8 | SRZN SURROZEN INC | $784.0K | 0.26% |
| 9 | RAPT RAPT THERAPEUTICS INC | $657.9K | 0.22% |
| 10 | TNYA TENAYA THERAPEUTICS INC | $620.8K | 0.2% |
| 11 | SRZNW SURROZEN INC | $3.1K | < 0.01% |
Values as reported on the Q2 2025 Form 13F. Every position is in the holdings table below.